Peritoneal Mesothelioma Malignant Advanced
1 clinical trials · Condition
◉ Watch Peritoneal Mesothelioma Malignant Advanced
| Record | Firm | Date |
|---|---|---|
| Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (NCT02029690) | Polaris Group | 2014-04-23 |
Track Peritoneal Mesothelioma Malignant Advanced automatically
Every clearance here is in the API, with alerts when new ones post.